CEO Devdatt Kurdikar discussed the performance expectations for the company's key product categories, noting growth in pen needles, stable syringes, and growth in safety products.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay
Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...
